Kane Biotech Stock Market Value
| KNBIF Stock | USD 0.03 0.0009 3.06% |
| Symbol | Kane |
Kane Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kane Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kane Biotech.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Kane Biotech on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Kane Biotech or generate 0.0% return on investment in Kane Biotech over 90 days. Kane Biotech is related to or competes with Biovaxys Technology. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies ... More
Kane Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kane Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kane Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.79 | |||
| Information Ratio | 0.0303 | |||
| Maximum Drawdown | 27.72 | |||
| Value At Risk | (5.30) | |||
| Potential Upside | 8.2 |
Kane Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kane Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kane Biotech's standard deviation. In reality, there are many statistical measures that can use Kane Biotech historical prices to predict the future Kane Biotech's volatility.| Risk Adjusted Performance | 0.0386 | |||
| Jensen Alpha | 0.2074 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0145 | |||
| Treynor Ratio | 0.77 |
Kane Biotech January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0386 | |||
| Market Risk Adjusted Performance | 0.78 | |||
| Mean Deviation | 2.45 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 11.79 | |||
| Coefficient Of Variation | 2432.43 | |||
| Standard Deviation | 5.65 | |||
| Variance | 31.91 | |||
| Information Ratio | 0.0303 | |||
| Jensen Alpha | 0.2074 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0145 | |||
| Treynor Ratio | 0.77 | |||
| Maximum Drawdown | 27.72 | |||
| Value At Risk | (5.30) | |||
| Potential Upside | 8.2 | |||
| Downside Variance | 139.07 | |||
| Semi Variance | 17.79 | |||
| Expected Short fall | (9.90) | |||
| Skewness | (0.52) | |||
| Kurtosis | 9.4 |
Kane Biotech Backtested Returns
Kane Biotech appears to be out of control, given 3 months investment horizon. Kane Biotech has Sharpe Ratio of 0.0411, which conveys that the firm had a 0.0411 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Kane Biotech, which you can use to evaluate the volatility of the firm. Please exercise Kane Biotech's Mean Deviation of 2.45, downside deviation of 11.79, and Risk Adjusted Performance of 0.0386 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kane Biotech holds a performance score of 3. The company secures a Beta (Market Risk) of 0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kane Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kane Biotech is expected to be smaller as well. Please check Kane Biotech's semi variance, day median price, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Kane Biotech's current price movements will revert.
Auto-correlation | 0.33 |
Below average predictability
Kane Biotech has below average predictability. Overlapping area represents the amount of predictability between Kane Biotech time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kane Biotech price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Kane Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Kane Pink Sheet
Kane Biotech financial ratios help investors to determine whether Kane Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.